PREVIEWS: "Daredevil," "Uncanny X-Men," & More Marvel Comics On Sale August 3, 2016
Showing results 88-107 of 215
DC Comics' "Justice League of America" #1 broke the 300K mark and Marvel's "Uncanny X-Men" relaunch performed strongly as well, "Vibe" didn't shake up the charts and Alan Moore topped the TPB list.
John Mayo looks at January's sales numbers, analyzing "Superior Spider-Man's" debut numbers and the overall Marvel NOW! performance while looking ahead to the challenge the Green Lantern franchise faces.
Marvel's "Superior Spider-Man" debuted to strong sales in January, outpacing the penultimate chapter of "Death of the Family" in Batman" #16 while the latest collections of "Fables" and "Saga" top the trades list.
John Mayo looks back on 2012's sales numbers, comparing the continuing strength of DC's New 52 top titles with Marvel's AvX and Marvel NOW! initiative, the across the board growth in the industry and more.
John Mayo returns with complete charts for the top 500 selling comics and trades through Diamond Comics for 2012, a year which saw "The Walking Dead" take the top spot on both charts.
John Mayo drills past the dominance of Marvel NOW! and Batman in the top ten December-releasing titles, looking at "Hawkeye" bucking traditional sales trends, Valiant's performance and more.
"Amazing Spider-Man" goes out with a bang as the title's final issue tops the December sales charts while the Marvel NOW! initiative, Batman's "Death of the Family" and Justice League round out the top ten.
John Mayo returns with his analysis of November's Marvel NOW! sales numbers, plus a look at DC Comics' New 52 performance from its 2011 launch through the latter portion of 2012.
November was a very good month for Marvel as the publisher's Marvel NOW! initiative had 8 of the top ten best-selling titles leading to overall sales domination while IDW's "My Little Pony" debuted at #15.
"Uncanny Avengers" #1 debuts with over 300K in sales, but can Marvel NOW! maintain a strong performance in the months ahead? John Mayo crunches the numbers on this and "The Walking Dead's" top 10 appearance.
Marvel NOW! opened big with Rick Remender and John Cassaday's "Uncanny Avengers" #1 topping October's sales while Robert Kirkman's "Walking Dead" shot up the charts to land in the top 10.
John Mayo gives his monthly analysis of the industry sales numbers, looking at DC Comics' September sales victory and explaining the challenges Marvel faces as it rolls out its Marvel NOW! initiative.
Marvel's penultimate "AvX" chapter took the number one position, but DC Comics' zero month issues dominated the rest of September's Top ten slots, leading the publisher to overall sales dominance for the month.
John Mayo takes a look at August's numbers, predicts the sales bump for the Marvel NOW! relaunch and looks at "Before Watchmen" and the past year of DC's New 52.
Marvel's "Avengers Vs. X-Men" reestablished its position at the top of the sales charts for July, while DC's "Batman: Earth One" performed well as the bestselling graphic novel of August.
John Mayo looks at the sales numbers for "The Walking Dead" #100, explaining the discrepancies between his estimates and Image's reported sales while looking at the title's potential future performance. UPDATED with more info from Image.
"The Walking Dead" easily took the number one sales slot for July, while DC Comics placed first in overall units and dollars, while "Batman: Earth One" was the best selling graphic novel.
John Mayo is back with analysis for the industry's June 2012 sales numbers, which saw DC Comics' Before Watchmen series' open big while AvX continues strong, though its companion titles lag behind.
Marvel's AvX remained at the top of the sales charts for June, while DC's "Batman" and "Justice League" were joined in the top ten by every Before Watchmen debut, all topping preorder numbers of 100,000.
John Mayo goes in-depth with May's numbers, examining the halo-effect of "AvX" and "Night of the Owls," explaining why "Earth 2" sales numbers may climb even higher and looking at the "Walking Dead" sales phenomenon.